Jubilant Life declines as promoters pare stake

Jubilant Life Sciences lost 1.32% to Rs 897.55 at 12:55 IST on BSE after the promoters of the company sold shares via bulk deal mechanism on Friday, 23 February 2018.

Meanwhile, the S&P BSE Sensex was up 227.36 points or 0.67% at 34,369.51.

On the BSE, 2.49 lakh shares were traded on the counter so far as against average daily volumes of 1.39 lakh shares in the past one quarter. The stock had hit a high of Rs 909.25 and a low of Rs 857.10 so far during the day. The stock had hit a record high of Rs 1,039 on 8 February 2018 and a 52-week low of Rs 600 on 25 October 2017.

The stock had outperformed the market over the past one month till 23 February 2018, gaining 0.01% compared with the Sensex's 5.53% fall. The stock had also outperformed the market over the past one quarter, advancing 37.58% as against the Sensex's 1.65% rise. The scrip had also outperformed the market over the past one year, surging 25.97% as against the Sensex's 18.17% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

Promoter Jubilant Advisors LLP sold 22.38 lakh shares of the company at Rs 917.43 per share in a bulk deal on the NSE on 23 February 2018. Promoter Jubilant Consumer offloaded 27.36 lakh shares at Rs 914 apiece. Copthall Mauritius Investment bought 27.50 lakh shares at Rs 914 per share.

Jubilant Advisors LLP held 1.41% and Jubilant Consumer 3.5% stake in Jubilant Life Sciences end December 2017.

On a consolidated basis, Jubilant Life Sciences' net profit surged 80.2% to Rs 212.84 crore on 41.9% growth in net sales to Rs 2041.47 crore in Q3 December 2017 over Q3 December 2016.

Jubilant Life Sciences is as an integrated pharmaceutical and life sciences solution provider offering products & services to its customers across the globe.

Powered by Capital Market - Live News